Loading current stock analysis…
Loading current stock analysis…
India
Reported ownership for FY2027-Q2 as of 2026-09-30.
As of 06 Nov 2026, 03:30 pm
For the quarter ended September 30, 2026, IKS reported revenue of ₹15,925 million (up 103.9% YoY) and EBITDA of ₹4,415 million (up 62.5% YoY). Profit after tax was ₹2,177 million (up 20.4% YoY). The company consolidated TruBridge, Inc., acquired for USD 557.0 million on July 9, 2026, which contributed to these figures over an 82-day period. Management stated the acquisition was PAT/EPS accretive from this quarter.
As of November 6, 2026, IKS closed at ₹1,655.10, down 5.8% in one day and -6.0% over the past month. The stock is currently trading below its 20-day moving average, with a daily Supertrend indicating a bearish trend. Immediate resistance sits at ₹1,666.84, while support is identified at ₹1,621.88. Over the longer term, the monthly Supertrend remains bullish.
Centrum Finverse Research included Inventurus Knowledge Solutions in its list of Diwali stock picks for Samvat 2083, citing corrected valuations and growth prospects. The brokerage projects upside potential ranging from 20% to 32% for the stock. This view is based on fundamental analysis and does not constitute a guaranteed return or investment advice.
As of 06 Nov 2026, 03:30 pm
Recent drawdown or price variability is high enough to warrant closer monitoring.
Primary driver: Price remains materially below a previous peak
The session opened materially below the previous close, indicating a sharp repricing at the open.
The price gap may increase short-term downside uncertainty and warrants review of the underlying context.
The session opened materially above the previous close, indicating a sharp repricing at the open.
The move may reflect new information; subsequent price follow-through is worth monitoring.
Latest complete financial results for Q2 FY27 and comparative quarterly trends.
| Metric | Q2 FY26 | Q1 FY27 | Q2 FY27(Latest) |
|---|---|---|---|
| Revenue From Operations | ₹781 crore | ₹894 crore | PEAK₹1,592 crore |
| Expenses | ₹556 crore | ₹643 crore | PEAK₹1,343 crore |
| Finance Costs | ₹16.1 crore | ₹10.1 crore | PEAK₹102 crore |
| Other Expenses | ₹102 crore | ₹144 crore | PEAK₹345 crore |
| Profit Before Exceptional Items And Tax | ₹229 crore | ₹256 crore | PEAK₹273 crore |
| Profit Loss For Period | ₹181 crore | ₹194 crore | PEAK₹213 crore |
| Tax Expense | ₹47 crore | ₹57.2 crore | PEAK₹59.8 crore |
| Basic Earnings Loss Per Share From Continuing And Discontinued Operations | ₹10.81 per share | ₹11.55 per share | PEAK₹12.98 per share |
| Diluted Earnings Loss Per Share From Continuing And Discontinued Operations | ₹10.58 per share | ₹11.31 per share | PEAK₹12.72 per share |
Revenue from operations rose 104% year on year and 78% sequentially to ₹1,592 crore in Q2 FY2026-27. Profit for the period increased 18% year on year and 10% quarter on quarter to ₹213 crore, as expenses more than doubled sequentially and finance costs climbed to ₹102 crore.
Basic EPS was ₹12.98 and diluted EPS was ₹12.72, up from ₹11.55 and ₹11.31, respectively, in Q1 FY2026-27. In Q2 FY2025-26, basic and diluted EPS were ₹10.81 and ₹10.58. Trailing twelve-month EPS was ₹47.80.
Tax expense was ₹59.8 crore, compared with ₹57.2 crore in Q1 FY2026-27. Current tax decreased to ₹56.1 crore from ₹68.3 crore.
Q2 brought a sharp increase in revenue, alongside substantially higher expenses and finance costs that limited profit growth. The balance sheet also expanded materially, with goodwill and noncurrent borrowings rising sharply; positive operating cash flow was much smaller than the investing outflow, which was largely offset by financing inflows.
Disclosed bulk and block transactions involving Inventurus Knowledge Solutions, shown for the latest 90 days.
Exchange disclosures and regulatory announcements for Inventurus Knowledge Solutions.
Inventurus Knowledge Solutions Limited published extracts of its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in Financial Express and Navshakti on November 7, 2026. The results had been reviewed by the Statutory Auditors and approved by the Board on November 5, 2026.
Inventurus Knowledge Solutions Limited has disclosed the audio recording of its Earnings Conference Call for Q2 FY 2026-27 results, which was held on November 06, 2026. The company informed the BSE and NSE that the recording is available on its website pursuant to Regulation 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Inventurus Knowledge Solutions Limited uploaded the audio recording of its earnings call to its website on November 6, 2026. The call concluded at 09:45:00, and the recording was uploaded at 11:56:00. This is a routine disclosure; the filing provides no substantive business information from the call.
The Board of Inventurus Knowledge Solutions Limited approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, at its meeting on November 5, 2026. Price Waterhouse Chartered Accountants LLP issued limited review reports with unmodified conclusions. The results report that TruBridge, Inc. was acquired on July 9, 2026, for an enterprise value of USD 557.0 million, financed through debt facilities; the financial statements also reflect substantial acquisition-related borrowing and consolidation changes. The filing additionally reports routine employee stock-option allotments and grants.
Inventurus Knowledge Solutions Limited reported Q2 FY27 results for the quarter ended September 30, 2026: revenue was INR 15,925 million, up 103.9% year over year and 78.2% quarter over quarter; EBITDA was INR 4,415 million, up 62.5% year over year and 49.7% quarter over quarter; and PAT was INR 2,177 million, up 20.4% year over year and 12.4% quarter over quarter. The company said TruBridge was consolidated for 82 days and that its acquisition was PAT/EPS accretive from Q2 FY27. The release also announced customer wins or expanding engagements and described the filing itself as a press release accompanying financial results.
Inventurus Knowledge Solutions Limited presented financial results for the quarter and half year ended September 30, 2026. For Q2 FY 27, revenue was INR 15,925 million (up 103.9% year over year), adjusted EBITDA was INR 4,415 million (up 62.5%), and profit attributable to IKS shareholders was INR 2,176 million (up 20.4%). The presentation also reported net debt and discussed acquisition-related expenses and business integration; the filing notice itself was the routine submission of the presentation under Regulation 30.
Integrated Filing- Financials|Original|
Integrated Filing- Financials|Original|
Recent market and company developments associated with Inventurus Knowledge Solutions.
Inventurus Knowledge Solutions Limited (NSE: IKS) reported strong Q2 FY27 financial results, with revenue growing 103.9% year-on-year and EBITDA rising 62.5%, driven by the consolidation of its TruBridge acquisition and sustained organic momentum. The company highlighted new customer wins across US healthcare providers, including White-Wilson Medical Center and UMass Memorial Health, while noting that the TruBridge integration is already accretive to PAT and EPS from this quarter.
Inventurus Knowledge Solutions Limited (NSE: IKS) reported strong Q2 FY27 financial results, with revenue rising 103.9% year-on-year and EBITDA increasing 62.5%, driven by the consolidation of its TruBridge acquisition and organic growth in its US healthcare operations. The company highlighted new customer wins, including partnerships with White-Wilson Medical Center and Evolve Orthopedic Partners, while executives noted that the integration is already accretive to PAT and EPS. Management emphasized a focus on realizing operational synergies and building an AI-native operating system for healt
Centrum Finverse Research has identified HFCL, Greaves Cotton, Manorama Industries, Inventurus Knowledge Solutions, and Varun Beverages as its Diwali stock picks for Samvat 2083, citing corrected valuations and growth prospects. The brokerage projects upside potential ranging from 20% to 32% for these fundamental stocks across sectors including telecom, power equipment, food products, FMCG, and business process management.
Sagility India, Sagility shares, IKS Health, Inventurus Knowledge Solutions, healthcare stocks, US healthcare, Nuvama Institutional Equities, Buy rating, target price, healthcare outsourcing, payer outsourcing, provider healthcare, AI-led healthcare, healthcare stocks India
From TCS' leadership transition to Infosys and HCLTech's growth guidance for FY27, there is a lot to focus on IT stocks as they count down to their second quarter results through the course of October and November.
Indian ER&D stocks, engineering research and development stocks, ER&D stocks, ER&D Q2FY27, Indian engineering stocks, ICICI Securities Q2FY27 preview, Tata Technologies Q2FY27, Cyient Q2FY27, L&T Technology Services Q2FY27, Tata Elxsi Q2FY27, KPIT Technologies Q2FY27, Tata Technologies stock, Cyient stock, LTTS stock, aerospace defence stocks India, semiconductor stocks India, best ER&D stocks to watch in Q2FY27, ICICI Securities top ER&D stock picks, Tata Technologies Cyient top picks, Indian ER&D stocks Q2FY27 expectations, engineering research and development sector outlook FY27
Market expert Raja Venkatraman shares his top stock picks for 24 September. Here’s his technical outlook and trade strategy.
Indian benchmark indices rose on Sept 22 due to falling crude oil prices and easing energy cost concerns, despite ongoing Middle East conflict. Nifty 50 gained 0.5% while Sensex increased 0.4%. A breakout above 23,600 could trigger renewed buying, with potential dips viewed as buying opportunities.
Comprehensive Section Breakdown for Inventurus Knowledge Solutions
Strategic Vision: Technology-enabled healthcare solutions for efficient care delivery.
• Technology-enabled healthcare solutions provider
• Global team including technologists and clinical staff
• Focus on enabling efficient delivery of high-quality care
Total income was ₹1,616 crore for the quarter ended 30 September 2026, compared with ₹899 crore in Q1 FY2026-27 and ₹785 crore in Q2 FY2025-26. Revenue from operations was ₹1,592 crore and other income was ₹23 crore.
Total expenses increased 109% sequentially to ₹1,343 crore. Other expenses rose to ₹345 crore from ₹144 crore in Q1 FY2026-27. Employee benefit expense was ₹804 crore and depreciation and amortisation expense was ₹90 crore. Finance costs increased to ₹102 crore from ₹10 crore in the prior quarter.
Profit before tax was ₹273 crore, up 7% sequentially and 19% year on year. Profit for the period was ₹213 crore, versus ₹194 crore in Q1 FY2026-27 and ₹181 crore in Q2 FY2025-26. The slower profit growth relative to revenue coincided with the larger reported expense base, including higher finance costs.
Operating cash flow was positive at ₹223 crore in the quarter. Investing activities used ₹5,038 crore, while financing activities generated ₹5,204 crore; reported free cash flow was negative ₹4,816 crore. Cash and cash equivalents stood at ₹529 crore on 30 September 2026, compared with ₹389 crore on 31 March 2026. Current investments were ₹152 crore at September-end, down from ₹220 crore at March-end.
Total assets expanded to ₹10,994 crore at 30 September 2026 from ₹4,268 crore at 31 March 2026. Goodwill increased to ₹5,236 crore from ₹1,326 crore. Noncurrent borrowings rose to ₹5,752 crore from ₹275 crore, while noncurrent financial liabilities were ₹5,867 crore. Equity attributable to owners of the parent was ₹3,341 crore, up from ₹2,800 crore.
Current trade receivables were ₹1,148 crore at 30 September 2026, compared with ₹564 crore at 31 March 2026. The increase in receivables accompanied substantial expansion in the reported asset and liability balances.
Category: B2B Services
Helps healthcare organizations manage financial processes from patient registration to payment collection.
Category: B2B Services
Provides assistance to clinicians, streamlining workflows and supporting patient care delivery.
Category: B2B Services
Focuses on helping healthcare providers achieve better patient outcomes and manage costs more effectively.
Core Thesis: The IKS Care Enablement Platform addresses administrative, clinical, and operational burdens in healthcare.
• Agility: Guides the company's approach to navigating opportunities. • Learning: Guides the company's approach to embedding insight. • Discovery: Guides the company's approach to pursuing innovation. • Community: Guides the company's approach to fostering collaboration.